EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study

Wenxian Sun, Aidi Shan, Pin Wang, Xiaodong Han, Chang Xu, Heya Luan, Shaoqi Li, Cuibai Wei iD

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 06.06.2026 · 81 (7)

DOI: 10.1093/gerona/glag135 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 22.05.2026. Verfasst von Wenxian Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Peroxidase, Cognitive Dysfunction. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mild cognitive impairment (MCI) is a key stage for early intervention in dementia, and its inflammatory mechanisms remain unclear. Myeloperoxidase (MPO), a key enzyme involved in inflammation and immune regulation, has not been fully studied in MCI. This multicenter longitudinal cohort study prospectively followed 133 patients with MCI for 12 months. Plasma MPO, Alzheimer’s disease (AD)-related biomarkers (p-Tau181, p-Tau217, glial fibrillary acidic protein , neurofilament light chain, and Aβ42/40), inflammatory cytokines (IL-1β, IL-6, and TNF-α), neuropsychological performance, and APOE genotype were assessed at baseline and follow-up. During follow-up, 58 patients showed cognitive deterioration and 75 remained non-deteriorated. At both baseline and the 12-month follow-up, the cognitive deterioration group showed higher MPO, IL-1β, and IL-6 levels than the non-deterioration group. Within-group longitudinal changes from baseline to follow-up were modest and were not statistically significant. Cross-sectional analyses showed that MPO was associated with IL-1β, IL-6, Aβ42/40, Mini-Mental State Examination (MMSE), and Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) at different assessment time points. Longitudinal delta analyses showed that changes in MPO were significantly correlated with changes in MMSE, IL-1β, and IL-6, but not with changes in ADAS-Cog or Aβ42/40. After adjustment for potential confounders, MPO remained an independent predictor of cognitive deterioration in MCI (OR = 1.018, 95% CI, 1.00-1.03, p = .015). Nomogram analysis showed that MPO was the most prominent predictor in the model. These findings suggest that elevated plasma MPO may serve as a clinically accessible prognostic biomarker for risk stratification in patients with MCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeroxidaseCognitive DysfunctionHumansFemaleMaleBiomarkersLongitudinal StudiesAgedProspective StudiesNeuropsychological TestsDisease ProgressionPrognosis

Stichwörter der Autor:innen

Alzheimer’s diseaseMild cognitive impairmentMyeloperoxidasePlasma biomarkerPrognosis

Substanzen

PeroxidaseBiomarkersMPO protein, human

Autor:innen und Institutionen

  • Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Innovation Center for Neurological Disorders and Department of Neurology, Xuanwu Hospital, Capital Medical University, National Clinical Research Center for Geriatric Diseases, Beijing, China.
  • Jinan Hospital of Xuanwu Hospital, Shandong First Medical University, Jinan, China.

ORCID-Profile: Cuibai Wei

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, W., Shan, A., Wang, P., Han, X., Xu, C., Luan, H., Li, S., & Wei, C. (2026). Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 81(7). https://doi.org/10.1093/gerona/glag135

Vancouver

Sun W, Shan A, Wang P, Han X, Xu C, Luan H, et al. Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2026;81(7). doi:10.1093/gerona/glag135

BibTeX
@article{Sun2026,
  author = {Sun, Wenxian and Shan, Aidi and Wang, Pin and Han, Xiaodong and Xu, Chang and Luan, Heya and Li, Shaoqi and Wei, Cuibai},
  title = {Plasma myeloperoxidase predicts cognitive decline in mild cognitive impairment: a multicenter longitudinal cohort study},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2026},
  volume = {81},
  number = {7},
  doi = {10.1093/gerona/glag135}
}
Kostenlos starten →